Bergom HE - Search Results

1

Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.

Sychev ZE, Day A, Bergom HE, Larson G, Ali A, Ludwig M, Boytim E, Coleman I, Corey E, Plymate SR, Nelson PS, Hwang JH, Drake JM. Sychev ZE, et al. Among authors: bergom he. Mol Cancer Res. 2024 May 2;22(5):452-464. doi: 10.1158/1541-7786.MCR-23-0976. Mol Cancer Res. 2024. PMID: 38345532 Free PMC article.

2

Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer.

Bergom HE, Sena LA, Day A, Miller B, Miller CD, Lozada JR, Zorko N, Wang J, Shenderov E, Lobo FP, Caramella-Pereira F, Marchionni L, Drake CG, Lotan T, De Marzo AM, Hwang J, Antonarakis ES. Bergom HE, et al. NPJ Genom Med. 2024 Jan 22;9(1):7. doi: 10.1038/s41525-024-00392-1. NPJ Genom Med. 2024. PMID: 38253539 Free PMC article.

3

Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.

Sychev ZE, Day A, Bergom HE, Larson G, Ali A, Ludwig M, Boytim E, Coleman I, Corey E, Plymate SR, Nelson PS, Hwang JH, Drake JM. Sychev ZE, et al. Among authors: bergom he. bioRxiv [Preprint]. 2023 Aug 5:2023.08.02.551697. doi: 10.1101/2023.08.02.551697. bioRxiv. 2023. PMID: 37577653 Free PMC article. Updated. Preprint.

4

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.

Chehrazi-Raffle A, Tukachinsky H, Toye E, Sivakumar S, Schrock AB, Bergom HE, Ebrahimi H, Pal S, Dorff T, Agarwal N, Mahal BA, Oxnard GR, Hwang J, Antonarakis ES. Chehrazi-Raffle A, et al. Among authors: bergom he. Clin Cancer Res. 2023 Oct 2;29(19):3948-3957. doi: 10.1158/1078-0432.CCR-23-1393. Clin Cancer Res. 2023. PMID: 37477913 Free PMC article.

5

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC.

White RE 3rd, Bannister M, Day A, Bergom HE, Tan VM, Hwang J, Dang Nguyen H, Drake JM. White RE 3rd, et al. Among authors: bergom he. Front Oncol. 2023 Jun 30;13:1210487. doi: 10.3389/fonc.2023.1210487. eCollection 2023. Front Oncol. 2023. PMID: 37456235 Free PMC article.

6

Saracatinib synergizes with enzalutamide to downregulate androgen receptor activity in castration resistant prostate cancer.

White RE, Bannister M, Day A, Bergom HE, Tan VM, Hwang J, Nguyen HD, Drake JM. White RE, et al. Among authors: bergom he. bioRxiv [Preprint]. 2023 Apr 25:2023.04.22.537922. doi: 10.1101/2023.04.22.537922. bioRxiv. 2023. PMID: 37163118 Free PMC article. Updated. Preprint.

7

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.

Hwang J, Shi X, Elliott A, Arnoff TE, McGrath J, Xiu J, Walker P, Bergom HE, Day A, Ahmed S, Tape S, Makovec A, Ali A, Shaker RM, Toye E, Passow R, Lozada JR, Wang J, Lou E, Mouw KW, Carneiro BA, Heath EI, McKay RR, Korn WM, Nabhan C, Ryan CJ, Antonarakis ES. Hwang J, et al. Among authors: bergom he. Clin Cancer Res. 2023 Jul 14;29(14):2702-2713. doi: 10.1158/1078-0432.CCR-22-3394. Clin Cancer Res. 2023. PMID: 37126020

8

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer.

Bae SY, Bergom HE, Day A, Greene JT, Sychev ZE, Larson G, Corey E, Plymate SR, Freedman TS, Hwang JH, Drake JM. Bae SY, et al. Among authors: bergom he. Front Endocrinol (Lausanne). 2023 Mar 29;14:1093332. doi: 10.3389/fendo.2023.1093332. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37065756 Free PMC article.

9

ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems.

Bergom HE, Shabaneh A, Day A, Ali A, Boytim E, Tape S, Lozada JR, Shi X, Kerkvliet CP, McSweeney S, Pitzen SP, Ludwig M, Antonarakis ES, Drake JM, Dehm SM, Ryan CJ, Wang J, Hwang J. Bergom HE, et al. Commun Biol. 2023 Apr 14;6(1):417. doi: 10.1038/s42003-023-04795-1. Commun Biol. 2023. PMID: 37059746 Free PMC article.

10

Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer.

Shi X, Day A, Bergom HE, Tape S, Baca SC, Sychev ZE, Larson G, Bozicevich A, Drake JM, Zorko N, Wang J, Ryan CJ, Antonarakis ES, Hwang J. Shi X, et al. Among authors: bergom he. NPJ Precis Oncol. 2022 Nov 2;6(1):80. doi: 10.1038/s41698-022-00323-2. NPJ Precis Oncol. 2022. PMID: 36323882 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page